Class A space stays in demand, but Twin Cities office vacancy climbs finance-commerce.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finance-commerce.com Daily Mail and Mail on Sunday newspapers.
Most people looking to lose weight with medications like Wegovy and Ozempic quit within a year, a new report finds. Drug shortages and cost may play a role.
The analysis from Prime Therapeutics highlights the hefty price tag of Wegovy and other weight loss and diabetes medicines, which are also known as GLP-1s.
The analysis from Prime Therapeutics highlights the hefty price tag of Wegovy and other weight loss and diabetes medicines, which are also known as GLP-1s.